217 Exploring glycosylation-dependent circuits for prediction of antitumor immune response and immunotherapy outcomes in melanoma and colorectal cancer
Biomarkers, Immune Monitoring and Novel Technologies
217 Exploring glycosylation-dependent circuits for prediction of antitumor immune response and immunotherapy outcomes in melanoma and colorectal cancer